Best 5 Indian Stocks & Trending Picks to Watch Now

Every trading week carries its own spirit, bringing different names into the spotlight for reasons that often extend beyond simple price moves. The following list highlights businesses that are currently shaping investor discussions and could influence near-term market sentiment. Here are five stock recommendations (India) to watch over the coming week.

Top Indian Stock Picks to Watch this Week

Here are the five Indian stock picks that are standing out with strong performance and market trends this week, 21st August 2025.

These are stocks that are ranked among the week’s top gainers, show high upside potential (ET Markets) and hold a stock score of 7 or above, based on five factors – earnings, fundamentals, relative valuation, risk and momentum.

Here are the top trending stocks:

CMP* Market Cap (₹ Cr) Potential Upside Stock Score 1W Return#
Bombay Burmah Trading Corporation 1,857 12,972 87.5% 10 1.52%
Action Construction Equipment 1,001 11,910 70% 10 7.07%
Anant Raj 554.5 19,039 57.3% 9 3.65%
Akums Drugs & Pharmaceuticals 484 7,588 52.4% 8 3.28%
Usha Martin 368.15 11,204 48.6% 9 4.19%

* CMP (₹)- Current Market Price as of 21st August 2025 (11.30 am).

# 1W Returns- 1 week returns as of 21st August 2025.

Please note, this is for informational purposes only. It is not a buy-sell call. Please carry out your own due diligence before taking positions.

Bombay Burmah Trading Corporation

Established in 1863, the company started with teak operations before shifting focus towards plantation crops. Its activities gradually widened to include coffee, tea, horticulture, processed foods, healthcare equipment and auto-electrical products. Each division adds to a portfolio that reflects steady diversification over time.

The share price stood at ₹1852.4 on 21 August 2025. Over the past three years, the stock has gained more than 105% despite a weaker one-year performance of -26.54%. Return on equity reached 19.93% in the FY25 and borrowings declined from ₹348.73 crore to ₹312.1 crore.

(₹ Cr) Jun 2025 Mar 2025 QoQ (%) Jun 2024 YoY (%)
Revenue 4,712 4,519 4.3 4,333 8.7
Operating Profit 724 802 -9.7 736 -1.6
Profit before tax 678 788 -14.0 656 3.4
Net Profit 241 309 -22.0 222 8.6

Action Construction Equipment

The company began operations in 1995 and today holds 63%+ market share in mobile and tower cranes in the country. Its reach covers construction, logistics, agriculture and infrastructure while products extend from cranes and loaders to tractors and specialised harvesting equipment. With distribution across more than 37 countries, the brand combines international presence with a broad domestic service network.

Current price is ₹1001. In three years the stock advanced more than 300%, yet the latest twelve months reflect a fall of 24.79%. Return on equity is 25.34%, though the recent quarter (June 2025) recorded a revenue contraction of 32.15%.

(₹ Cr) Jun 2025 Mar 2025 QoQ (%) Jun 2024 YoY (%)
Revenue 652 961 -32.15 734 -11.17
Operating Profit 94 169 -44.38 99 -5.05
Profit before tax 128 161 -20.50 112 14.29
Net Profit 98 119 -17.65 84 16.67

Anant Raj

Founded in 1969, the real estate company has established a presence across Delhi & NCR regions with projects spanning residential, commercial, hospitality and IT spaces.  Nearly 9.96 million square feet of projects have been completed and also operates 28 megawatts of data centre capacity as of Q1FY26. 

Current market price stands at ₹554. Over three years the stock multiplied more than seven times, though the last year showed a weaker 7.49%. Return on equity has been rising for five years, supported by a reduction in debt from ₹589.19 crore to ₹420.55 crore.

(₹ Cr) Jun 2025 Mar 2025 QoQ (%) Jun 2024 YoY (%)
Revenue 592 541 9.43 472 25.42
Operating Profit 151 142 6.34 103 46.60
Profit before tax 152 142 7.04 105 44.76
Net Profit 126 119 5.88 91 38.46

Akums Drugs & Pharmaceuticals

Formed in 2004, the organisation has grown into a key provider of contract development and manufacturing services within the pharmaceutical sector. In the first quarter of FY26, revenue share stood at 79.4% from CDMO, 10.5% from domestic branded formulations, 4.4% from APIs, 3.4% from international branded formulations and 2.3% from trade generics. Each vertical adds to a structure where CDMO remains the primary driver.

Akums Drugs came out with a book-built IPO of ₹1,856.74 crore in August 2024. The stock trades at ₹484. Over one year performance shows a decline of 52.25%. Return on equity is 11.09% and return on capital employed is 11.27%.

(₹ Cr) Jun 2025 Mar 2025 QoQ (%) Jun 2024 YoY (%)
Revenue 1,024 1,056 -3.03 1,019 0.49
Operating Profit 129 94 37.23 128 0.78
Profit before tax 96 75 28.00 87 10.34
Net Profit 63 148 -57.43 60 5.00

Usha Martin

The company manufactures steel wires, ropes, strands and accessories, along with telecom cables and allied machinery. Its focus remains on high-value products such as specialised ropes and low relaxation prestressed concrete strands. In India, it holds 65–70% share of the wire rope market, supported by a wide distribution network. Demand from elevators in Tier 2 and Tier 3 cities, as well as usage in ports and cranes, continues to expand.

The stock trades at ₹368.15. Over 3 years it gained 164.89%, while in the past 1 year it delivered a rise of 10.96%.

(₹ Cr) Jun 2025 Mar 2025 QoQ (%) Jun 2024 YoY (%)
Revenue 1,024 1,056 -3.03 1,019 0.49
Operating Profit 129 94 37.23 128 0.78
Profit before tax 96 75 28.00 87 10.34
Net Profit 63 148 -57.43 60 5.00

Conclusion

This blog is centred on stocks that show possibilities in the essential sectors of the Indian market. Deep diving into their latest achievements and tactical moves, investors can get valuable inputs for making the right choices. It will be crucial to stay alert and closely monitor the results and developments across different sectors as the market evolves. Being thoroughly versed in the potential research and implementing the latest trends carefully will enable one to not only manage potential hazards but also exploit emerging opportunities efficiently.

Lakshmi Sundari A.

Leave a Reply

Your email address will not be published. Required fields are marked *